Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
In Corsica, the Prefect of the Haute-Corse department has announced that establishments open to the public such as bars and restaurants will have to c...
Read More
U-Turns- Many people say they're confused about the fresh restrictions aimed at reducing the spread of coronavirus in the Alpes Maritimes....
Read More
Aude inferno- A massive fire that’s so far destroyed more than 900 hectares of forest land in the Aude department is still not completely under contro...
Read More
The president of the Scientific Council Jean-Francois Delfraissy has said that there will probably be 50,000 Covid-19 caes per day in France at the be...
Read More
